Understanding Eosinophils in Allergic Conditions
Spatial and Temporal Resolution of EosinophilSpecialization in Allergic Microenvironments
This project aims to understand how certain immune cells called eosinophils behave and survive in tissues during allergic conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11167694 on NIH RePORTER |
What this research studies
Eosinophils are key players in many allergic conditions, and while new drugs target these cells, we don't fully understand why these treatments don't always work for everyone. This project looks at how eosinophils specialize and survive for longer than expected in tissues, moving beyond the traditional view that they are only harmful. We want to learn what helps them differentiate, how they interact with surrounding tissues, and what keeps them alive. This deeper understanding could help us develop better, more targeted treatments for allergic diseases.
Who could benefit from this research
Good fit: Patients with allergic and inflammatory diseases characterized by eosinophilic inflammation, such as asthma or eczema, might eventually benefit from the insights gained from this research.
Not a fit: Patients whose conditions are not related to eosinophil activity or allergic inflammation would likely not see direct benefit from this specific foundational research.
Why it matters
Potential benefit: If successful, this work could lead to more effective and targeted treatments for allergic and inflammatory diseases by providing a better understanding of eosinophil behavior.
How similar studies have performed: While eosinophil-depleting drugs are being developed, this project explores a novel aspect of eosinophil biology, specifically their tissue-resident functions and survival mechanisms, which is an active area of new discovery.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Dunn, Julia Louise Malik — University of Colorado Denver
- Study coordinator: Dunn, Julia Louise Malik
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.